Navigation Links
Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
Date:2/19/2008

pment. In addition to the over 56 ErbB-targeted agents in development (35 in current clinical trials), numerous molecular markers/pathways are being recognized as contributing to the success or failure of the ErbB pathway inhibitors. A series of reports (http://www.newmedinc.com/futonc/sample.pdf) on currently approved therapeutics as well as those in development targeting the ErbB pathway, including EGFr and HEr2 inhibitors, published by Future Oncology (http://www.newmedinc.com), highlights the contribution of molecular profiling in the characterization of cancer and its treatment.

New Medicine's Oncology KnowledgeBASE (nm|OK) is a Complete Knowledge Environment in Drug Development in Cancer

Unlike standard drug databases, nm|OK residing at http://www.nmok.net, is designed to specifically provide a fully realized environment reflecting every aspect of drug development in oncology. nm|OK is an edited, inclusive analysis of all aspects of oncology drug development worldwide, including technologies, targets, companies, business affiliations, medical and clinical developments, protocols and results of thousands of clinical trials, and global markets, among others. Currently, nm|OK profiles over 2,000 anticancer agents/technologies in current development (over 4,000 drugs overall) or on the market, more than 1,200 targets implicated in malignancy, and more than 2,000 companies developing/marketing products in the oncology sector. Protocols, interim and final results are presented for thousands of trials, searchable by both novel and approved agents in monotherapy or combination therapy regiments. In addition, nm|OK describes hundreds of diagnostic, prognostic, and theragnostic methodologies and products as they relate to treatment candidate selection, evaluation of the results of clinic
'/>"/>

SOURCE New Medicine, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
2. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
3. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
4. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
5. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
7. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
8. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
9. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
10. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
11. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July, 29  2014 ISPE—the International Society ... John Bournas as President and CEO, ... to leave the Society last fall.  Mr. Bournas ... in the healthcare association industry as well as ... a clear vision for the expansion of its ...
(Date:7/29/2014)... , July 29, 2014  Roche (SIX: RO, ... Association for Clinical Chemistry (AACC) 2014 Clinical Lab Expo ... on the unique ways Roche is partnering with customers ... "Our customers tell us every day that they,re looking ... they deliver in their labs and offices," said ...
(Date:7/29/2014)... July 29, 2014 Research and Markets ... Respiratory Devices Market 2014-2018" report to their offering. ... A respiratory device is a medical device used to ... difficulty in breathing and cannot achieve adequate oxygen levels ... cystic fibrosis, asthma, COPD, and ARDS require the need ...
Breaking Medicine Technology:ISPE Hires Healthcare Association Exec as CEO 2ISPE Hires Healthcare Association Exec as CEO 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4Global Respiratory Devices Market 2014-2018 2
... April 28, 2011 ResMed Inc. (NYSE: RMD ... ended March 31, 2011.  Revenue for the quarter ended March ... 12% increase on a constant currency basis) over the quarter ... 2011, income from operations was $64.0 million and net income ...
... Financial Highlights ($ in millions, except ... , $109.5 , 28.8% increaseTotal Net Product Revenue , ... , 24.7% increaseAldurazyme BioMarin Net Product Revenue* , $18.7 ... increaseFirdapse Net Product Revenue , $3.1 , $0.1GAAP Net ...
Cached Medicine Technology:ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 2ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 3ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 4ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 5ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 6BioMarin Announces First Quarter 2011 Financial Results 2BioMarin Announces First Quarter 2011 Financial Results 3BioMarin Announces First Quarter 2011 Financial Results 4BioMarin Announces First Quarter 2011 Financial Results 5BioMarin Announces First Quarter 2011 Financial Results 6BioMarin Announces First Quarter 2011 Financial Results 7BioMarin Announces First Quarter 2011 Financial Results 8BioMarin Announces First Quarter 2011 Financial Results 9BioMarin Announces First Quarter 2011 Financial Results 10BioMarin Announces First Quarter 2011 Financial Results 11
(Date:7/29/2014)... (GSA) the nation,s largest interdisciplinary organization devoted ... E. Lckenhoff, PhD, of Cornell University as the 2014 ... Foundation Award in Behavioral and Social Gerontology. , This ... in behavioral and social gerontology. Individuals who have received ... The award is given by GSA in conjunction with ...
(Date:7/29/2014)... July 29, 2014 The report ... Cosmetics), Type (Rotary, Volumetric, Aseptic, Net Weight), Process ... Geography - Global Trend & Forecast to 2019”, ... into food, beverage, pharmaceutical, and cosmetic segments with ... each of these segments, in terms of value. ...
(Date:7/29/2014)... Calif. (PRWEB) July 29, 2014 July ... drug abuse directly at the source? That’s the big ... an innovative prescription drug abuse risk program developed by ... hundreds of applicants worldwide to be part of ... 10-12 in San Francisco, CA. The Hive is a ...
(Date:7/29/2014)... -- With the increasing use of electronic medical ... growing demand for a computerized version of the ... States. In a new study, researchers from the ... Institute report that substantial work lies ahead to ... guidelines into computerized prompts for physicians, but the ...
(Date:7/29/2014)... 29, 2014 The Los Angeles ... recently participated in a community program that helps homeless ... volunteers partnered with the San Fernando Valley Rescue Mission ... , The San Fernando Valley Rescue Mission offers emergency ... mission's Family Emergency Shelter provides housing and basic needs ...
Breaking Medicine News(10 mins):Health News:Löckenhoff earns GSA's 2014 Baltes Foundation Award 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 3Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 4Health News:SafeUseNow Selected to Showcase at TEDMED Hive 2014 2Health News:SafeUseNow Selected to Showcase at TEDMED Hive 2014 3Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 2Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 3Health News:The Discovery House Employees Volunteer at Local Rescue Mission 2Health News:The Discovery House Employees Volunteer at Local Rescue Mission 3
... off in Northwestern PA , , HARRISBURG, Pa., June ... the harms of tobacco use on their unborn babies, the ... Control Program are launching a new smoking cessation campaign to ... that region of the state. , , "More ...
... as QM Certified Scoring Partner , , LINCOLN, ... Innoventz, a clinical research organization (CRO) for medical device ... QM Certified Scoring Partner. QualityMetric developed the QM Certified ... many in the life sciences industry -- the accuracy ...
... San Diego, CA, June 22, 2009 Because of ... and children with asthma is recommended by the Advisory ... call for annual influenza vaccination of at least 60% ... for Disease Control and Prevention (CDC) investigators have determined ...
... Mass., June 22 Joseph F. Finn, Jr., C.P.A. ... on developing GCS-100 for treatment of three blood-borne cancers: ... large B cell lymphoma ("DLBCL"). In clinical studies, ... CLL and in combination with existing therapy in MM. ...
... Martha Lucas, Ph.D., L.Ac., Denver-based acupuncturist and practitioner of Traditional ... to Cosmetic Acupuncture for Anti-aging. The announcement is ... tells the history of vanity and what women have been ... Now there,s a healthy, safe option - Cosmetic Acupuncture. ...
... The ... for their own health. Celebrity Diagnosis is an innovative approach to personalized medicine that ... unique feature of Celebrity Diagnosis is the casebook, a convenient and portable information packet ... ...
Cached Medicine News:Health News:State Launches New Campaign to Help Pregnant Smokers Go Tobacco-Free 2Health News:Innoventz Certified to Score Both the SF-36v2 and SF-12v2 Health Surveys 2Health News:Innoventz Certified to Score Both the SF-36v2 and SF-12v2 Health Surveys 3Health News:Adults with asthma not getting their flu shots 2Health News:Prospect Therapeutics Inc.'s GCS-100 Has Focused on Developing Treatment for Three Blood-Borne Cancers 2Health News:Denver-Based Acupuncturist, Dr. Martha Lucas, Releases New Book: 'Vanity Calamity: Your Guide to Cosmetic Acupuncture for Anti-aging' 2Health News:CelebrityDiagnosis.com Presents Famous Patients As Medical Lessons 2Health News:CelebrityDiagnosis.com Presents Famous Patients As Medical Lessons 3
Ideal for abdominal and flank procedures....
Male Abdominal Supporter...
Zippered Abdominal Girdle...
CDIs 2nd Stage Abdominoplasty Girdle - a feminine, easy pull-on version of the 8000 series...
Medicine Products: